Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

Abstract:

Human coronaviruses (hCoVs) can be divided into low pathogenic and highly pathogenic coronaviruses. The low pathogenic CoVs infect the upper respiratory tract and cause mild, cold-like respiratory illness. In contrast, highly pathogenic hCoVs such as severe acute respiratory syndrome CoV (SARS-CoV) and Middle East respiratory syndrome CoV (MERS-CoV) predominantly infect lower airways and cause fatal pneumonia. Severe pneumonia caused by pathogenic hCoVs is often associated with rapid virus replication, massive inflammatory cell infiltration and elevated pro-inflammatory cytokine/chemokine responses resulting in acute lung injury (ALI), and acute respiratory distress syndrome (ARDS). Recent studies in experimentally infected animal strongly suggest a crucial role for virus-induced immunopathological events in causing fatal pneumonia after hCoV infections. Here we review the current understanding of how a dysregulated immune response may cause lung immunopathology leading to deleterious clinical manifestations after pathogenic hCoV infections.

SEEK ID: https://fairdomhub.org/publications/511

DOI: 10.1007/s00281-017-0629-x

Projects: COVID-19 Disease Map

Publication type: Journal

Journal: Seminars in Immunopathology

Citation: Semin Immunopathol 39(5):529-539

Date Published: 1st Jul 2017

Registered Mode: imported from a bibtex file

Authors: Rudragouda Channappanavar, Stanley Perlman

help Submitter
Citation
Channappanavar, R., & Perlman, S. (2017). Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. In Seminars in Immunopathology (Vol. 39, Issue 5, pp. 529–539). Springer Science and Business Media LLC. https://doi.org/10.1007/s00281-017-0629-x
Activity

Views: 1184

Created: 8th Apr 2020 at 20:13

Last updated: 8th Dec 2022 at 17:26

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.16.0)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH